1. Kia, Demis A, Zhang, David, Guelfi, Sebastian, Hardy, John, Wood, Nicholas W. . Identification of Candidate Parkinson Disease Genes by Integrating Genome-Wide Association Study, Expression, and Epigenetic Data Sets. In JAMA neurology, 78, 464-472. doi:10.1001/jamaneurol.2020.5257. https://pubmed.ncbi.nlm.nih.gov/33523105/
2. Kalogeropulou, Alexia F, Freemantle, Jordana B, Lis, Pawel, Polinski, Nicole K, Alessi, Dario R. . Endogenous Rab29 does not impact basal or stimulated LRRK2 pathway activity. In The Biochemical journal, 477, 4397-4423. doi:10.1042/BCJ20200458. https://pubmed.ncbi.nlm.nih.gov/33135724/
3. Purlyte, Elena, Dhekne, Herschel S, Sarhan, Adil R, Pfeffer, Suzanne R, Alessi, Dario R. 2017. Rab29 activation of the Parkinson's disease-associated LRRK2 kinase. In The EMBO journal, 37, 1-18. doi:10.15252/embj.201798099. https://pubmed.ncbi.nlm.nih.gov/29212815/
4. Rivero-Ríos, Pilar, Romo-Lozano, Maria, Fernández, Belén, Fdez, Elena, Hilfiker, Sabine. 2020. Distinct Roles for RAB10 and RAB29 in Pathogenic LRRK2-Mediated Endolysosomal Trafficking Alterations. In Cells, 9, . doi:10.3390/cells9071719. https://pubmed.ncbi.nlm.nih.gov/32709066/
5. Unapanta, Alexandra, Shavarebi, Farbod, Porath, Jacob, Di Pietro, Santiago M, Hiniker, Annie. 2023. Endogenous Rab38 regulates LRRK2's membrane recruitment and substrate Rab phosphorylation in melanocytes. In The Journal of biological chemistry, 299, 105192. doi:10.1016/j.jbc.2023.105192. https://pubmed.ncbi.nlm.nih.gov/37625589/